Jubilant Life Sciences zooms 15% on strong Q3 results

The stock hit a record high of Rs 931, up 15% on BSE after the pharmaceutical company reported a strong 78% year on year jump in consolidated net profit at Rs 2.13 billion in Q3FY18.

Powered by WPeMatico

Scroll to top